• Home/
  • Press Releases/
  • Global Plasma Therapy Market to Reach US$389.7 mn by 2025 as Frequency of Chronic Diseases Rises

QY Research announced the publication of a latest report, titled “Global Plasma Therapy Market Report, History and Forecast 2014-2025, Breakdown Data by Companies, Key Regions, Types and Application”. The research report discusses the future of the overall market and the dynamic forces governing its trajectory. Analysts have studied the drivers and restraints present in the overall market to explain the growth rate of the global plasma therapy market. Furthermore, analysts have tracked the development in the healthcare sector to provide the readers a comprehensive outlook of the market.

According to the research report, the global plasma therapy market was valued at US$197 mn in 2018 and is expected to reach US$389.7 mn by the end of 2025. During the forecast years of 2019 and 2025, the global market for plasma therapy is projected to register a CAGR of 10.0%.

Global Plasma Therapy Market: Drivers and Restraints

Plasma therapy uses platelet-rich plasma protein that is extracted from blood to treat the patient. The high incidence of life-altering conditions such as idiopathic thrombocytopenic purpura (ITP), chronic inflammatory demyelinating polyneuropathy (CIPD), and multifocal motor neuropathy (MMN) are expected to boost the global plasma therapy market. Furthermore, the rise of contagious diseases has created a positive impact on the global market for plasma therapy.

Growth of the global plasma therapy market can also be attributed to the rapid pace of technological advancements that brought in affordable protein fractioning technologies from plasma. Supportive government incentives for development of plasma derived medicine, as blood donation drives gain momentum, are expected to favor market growth during the forecast period.

Global Plasma Therapy Market: Segments

The global plasma therapy market is segmented on the basis of product and application. The product segment includes pure PRP, leucocyte-rich PRP, and leukocyte-rich fibrin (L-PRF). In terms of application, the market is segmented into orthopaedic, dermatology, cardiac muscle injury, dental, nerve injury, and others.

Global Plasma Therapy Market: Regional Segmentation

In terms of geography, the global plasma therapy market is segmented into North America, Europe, China, Southeast Asia, India, and Central and South America. Out of these, North America is expected to lead the global plasma therapy market. This dominance will be attributable to the well-established healthcare sector, growing number of blood donation drivers, and advanced procedures for protein fractioning. The report suggests that this regional market held a share of 53.54% in 2018, accounting for US$105.53 mn. Analysts project that Europe is likely to follow the lead as it held a share of 26.10% in 2018. 

Global Plasma Therapy Market: Competitive Landscape

Some of the leading players operating in the global plasma therapy market are Terumo, DePuy Synthes, Arthrex, Zimmer Biomet, and EmCyte. The research report offers an insightful take on the competitive landscape present in the overall market. It offers valuable information about the financial outlook of these companies, their research and development plans, and business expansion strategies. Companies are expected to focus on improving patient outcomes and experience while devising kits. 

Full Report Overview@ https://www.qyresearch.com/index/detail/1050563/global-plasma-therapy-market

©2007-2026 QY Research All Rights Reserved.